AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer.
Clinical trial NCT00454805 · COMPLETED
Trial details
- NCT number
- NCT00454805
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2008-12-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.